- Investigator
- Francesco Franchi
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Treats Adults
Francesco Franchi, MD
Cardiologist
- Additional languages:
- Italian
(904) 383-1011
Request appointment online
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 83 publications
- Percutaneous Coronary Intervention , 49 publications
- Purinergic P2Y Receptor Antagonists , 43 publications
- Clopidogrel , 36 publications
Research activity
Active clinical trials
My publications
Filter publications
143 publications
2024
Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD
JACC: Basic to Translational Science
2024
Evaluating the Effect of Estimating Renal Function With the CKD鈥怑PI 2021 Equation on the ABCD鈥怗ENE Score for Clopidogrel Response Prediction
Clinical Pharmacology & Therapeutics
2024
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention.
Journal of the American Heart Association
鈥�2024
P2Y12 Inhibition in Patients Requiring Oral聽Anticoagulation After Percutaneous聽Coronary Intervention
JACC: Cardiovascular Interventions
2024
The Lipid-Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet Reactivity.
Thrombosis and haemostasis
鈥�